Medicines Company (MDCO) Profile

Profile for Medicines Company (MDCO)

After Hours: $ 20.75

0.00 (0.00%)

Volume: 345

4:50 PM EST Feb 10, 2012


Business Description: Medicines Company is a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace.

Address:	8 Sylvan Way, Parsippany, NJ, 07054
Telephone:	(973) 290-6000	Website:	www.themedicinescompany.com
Facsimile:	(973) 656-9898	Email:	investor.relations@themedco.com


Details

CEO:	Dr. Clive A. Meanwell,M.D.
Employees:	420	Market Cap:	1.12 b
Issue Type:	CS
Auditor:	Ernst & Young LLP
Last Audit:	Unqualified
Indices:	Drug Manufacturers - Other


Industry Classifications

Sector:	Healthcare	CIK:	0001113481
Industry:	Drugs
Sub-Industry:	Drug Manufacturers - Other
NAICS:	Pharmaceutical Preparation Manufacturing (325412)
SIC:	Pharmaceutical Preparations (2834)

Tags for Medicines Company

Research stocks or mutual funds related to Medicines Company by keywords or tags. Find companies that have a similar focus to MDCO. The keywords below have been associated to MDCO by either user submission or electronic means.

schering plough health care products biotech research pharmaceuticals research pharmaceutical branding pharmaceutical industry strategy pharmaceutical publication pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceutical investment financial annual report pharmaceutical research and development annual report pharmaceutical manufacturing company dupont pharmaceuticals pharma manufacturing company earnings pharma license novartis pharmaceuticals generic products pharmaceutical cro pharma consulting active pharmaceutical ingredients health care marketing pharmaceutical sales pharma consultants pharmaceutical distributors mckesson products biotech corporation pharmaceutical development pharmaceutical reports pharmaceutical magazine biotech pharmaceutical pr Drugs annual report of company massengill products corporate annual report pharma r&d pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical conference pharmaceutical manufacturing pharmaceutical translations pharmaceutical formulation electronic medicines compendium pfizer pharmaceuticals contract pharmaceutical pharmaceutical consulting pharmaceutical events

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.